EBMT-EHA CAR-T 2019 | HCP collaboration in CAR-T cell therapy
Erik Aerts
• 14 Feb 2019
Erik Aerts, RN, University Hospital Zurich, Zurich, Switzerland, discusses some of the ways side effects can be managed such as the close monitoring of patients. He also mentions the importance of collaboration between wards and treatment teams following CAR T-cell treatment. This video was recorded at the 1st European CAR T-Cell Meeting in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).
